Circulating Tumor DNA to Guide Changes in Standard of Care Chemotherapy
Conditions
- Metastatic HER2-Negative Breast Carcinoma
- Metastatic Triple-Negative Breast Carcinoma
Interventions
- PROCEDURE: Biospecimen Collection
- PROCEDURE: Computed Tomography
- PROCEDURE: Magnetic Resonance Imaging
- PROCEDURE: Biospecimen Collection
- BIOLOGICAL: Sacituzumab Govitecan
Sponsor
Vanderbilt-Ingram Cancer Center
Collaborators